• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Takeda

Takeda lungs ESMO 2023
Biotech

Insilico inks partnership via $600M biobuck collab with Takeda

Insilico Medicine has signed a potential $600 million deal with Takeda to team on asset discovery across the pharma's therapeutic areas of interest.
Will Maddox Jul 1, 2026 8:30pm
Pfizer

A 5-month sprint: Inside Pfizer's $10B deal with Innovent

Jun 21, 2026 10:41pm
Eclipse

Intellia touts ‘paradigm-shifting’ HAE data

Jun 15, 2026 10:37am
head to head against clash football helmets fight combat

Takeda’s TYK2 inhibitor beats BMS’ Sotyktu in psoriasis showdown

Jun 11, 2026 7:00am
An arrow incrementally going up stairs before pointing straight up Blue background

Innovent, fresh from $1.2B deal, posts key win for CLDN18.2 ADC

Jun 4, 2026 7:47am
ASCO
Favicon Fierce Pharma

At ASCO, China biotech industry cements its coming of age

Jun 3, 2026 8:50am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings